APRICOT: Anaesthesia PRactice In Children Observational Trial
APRICOT
1 other identifier
observational
30,000
30 countries
35
Brief Summary
The aims of the APRICOT study are:
- To establish the incidence of severe critical events in children undergoing anesthesia in Europe.
- To describe the differences in paediatric anaesthesia practice throughout Europe.
- To study the potential impact of this variability on the occurrence of severe critical events (Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2014
35 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2013
CompletedFirst Posted
Study publicly available on registry
June 17, 2013
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedOctober 14, 2015
October 1, 2015
10 months
May 28, 2013
October 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of severe critical events
Incidence of the following severe critical events defined as any incident occurring during and up to 60 minutes after anaesthesia or sedation (PACU), requiring immediate intervention and that may lead to major disability and/or death: * Laryngospasm * Bronchospasm * Pulmonary aspiration * Drug error * Anaphylaxis * Cardiovascular instability * Neurological damage * Perianaesthetic Cardiac arrest * Postanaesthetic Stridor (in the PACU)
Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards
Secondary Outcomes (2)
Risk factors for the occurrence of severe critical events
Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards
Consequences of the critical events: irreversible damage, in-hospital mortality
in-hospital and up to 30 days
Eligibility Criteria
Children from birth to 15 years included admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or admitted for a diagnostic procedure under general anaesthesia (such as endoscopy, radiology…) or admitted out-of-hours for emergency procedures
You may qualify if:
- Age: from birth to 15 years included
- All children admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or under regional anaesthesia alone. This includes all kind of surgeries and procedures requiring anaesthesia and analgesia to be performed such as central venous access, burn care, cast, etc.,
- Children admitted for a diagnostic procedure under sedation (performed by an Anaesthetist) or general anaesthesia (such as endoscopy, radiology (CT-scan, MRI), cardiac catheterisation and electrophysiology, PET-scan, radiotherapy, lumbar and bone marrow puncture, biopsies), diagnostic procedure under general anaesthesia (such as endoscopy, radiology…)
- Children admitted for urgent or emergency procedure performed in- or out-of-hours.
You may not qualify if:
- Children admitted directly from the intensive care units to the operating rooms
- Anaesthesia procedures in the neonatal or paediatric intensive care units.
- Age: All children aged ≥ 16 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (38)
Medical University Graz
Graz, A-8034, Austria
Cliniques Universitaires St Luc
Brussels, 1200, Belgium
General Hospital Pula
Pula, 52100, Croatia
University Children´s Hospital
Brno, 61300, Czechia
Odense University Hospital
Odense, Denmark
Tartu University Hospital
Tartu, 51014, Estonia
Oulu University Hospital
Oulu, 90220, Finland
Turku University Hospital
Turku, 20521, Finland
CHU Lille
Lille, France
Lapeyronie University Hospital
Montpellier, 34000, France
Universitaetsklinikum Leipzig
Leipzig, 04103, Germany
Cnopf'sche Kinderklinik/Klinik Hallerwiese
Nuremberg, 90419, Germany
Asklepios Klinik Sankt Augustin GmbH - Department of Paediatric Anaesthesia
Sankt Augustin, 53757, Germany
Gibraltar Health Authority, St. Bernard´s Hospital
Gibraltar, 11111, Gibraltar
Children Hospital P&A Kyriakoy
Athens, 11527, Greece
Our Ladys Children's Hospital
Dublin, 12, Ireland
Schneider Children's Medical center of Israel
Petah Tikva, 49202, Israel
Instituto Giannina Gaslini
Genoa, 6100, Italy
University Clinical Center of Kosovo
Pristina, 10000, Kosovo
Children University Hospital
Riga, 1004, Latvia
Vilnius Children Hospital
Vilnius, 8406, Lithuania
Mater Dei Hospital MSD
Msida, 2090, Malta
Maastricht University Medical Center MUMC
Maastricht, Netherlands
Oslo University Hospital, Rikshospitalet
Oslo, 421, Norway
Clinical University Hospital Department of Anaesthesiology and Intensive Care
Wroclaw, 50-556, Poland
Centro Hospitalar Lisboa Norte - Hospital de Santa Maria
Lisbon, 1649-035, Portugal
Spitalul de Copiin Maria Curie
Bucharest, 41451, Romania
Pirogov Russian National Research Medical University
Moscow, 117997, Russia
University Childrens hospital
Belgrade, 11000, Serbia
Paediatric District Hospital
Banská Bystrica, 97409, Slovakia
University Klinical Centre Ljubljana
Ljubljana, 1000, Slovenia
Hospital Sant Joan Déu
Esplugues de Llobregat, 8950, Spain
Queen Silvis Childrens Hospital Sahlgrens University Hospital
Gothenburg, SE 41685, Sweden
Geneva University Hospitals
Geneva, Switzerland
Anästhesie Kinderspital Klinik für Anästhesie, Intensivmedizin, Rettungsmedizin und Schmerztherapie (KLIFAIRS) Luzerner Kantonsspital Spitalstrasse
Lucerne, 6000, Switzerland
Cukurova University Faculty Of Medicine
Adana, 01330, Turkey (Türkiye)
P.L.Shupyk National Medical Academy of Postgraduate Education, Municipal Children's Hospital #1
Kyiv, 4209, Ukraine
Royal Hospital For Sick Children
Glasgow, Scotland, G3 8SJ, United Kingdom
Related Publications (5)
Dagher K, Benvenuti C, Virag K, Habre W. The Incidence of Postoperative Complications Following Lumbar and Bone Marrow Punctures in Pediatric Anesthesia: Insights From APRICOT. J Pediatr Hematol Oncol. 2024 Apr 1;46(3):165-171. doi: 10.1097/MPH.0000000000002849. Epub 2024 Mar 4.
PMID: 38447107DERIVEDDahmani S, Laffargue A, Dadure C, Veyckemans F; French APRICOT trial group. Description of practices and complications in the French centres that participated to APRICOT: A secondary analysis. Anaesth Crit Care Pain Med. 2019 Dec;38(6):637-645. doi: 10.1016/j.accpm.2019.06.001. Epub 2019 Jun 11.
PMID: 31200009DERIVEDVirag K, Sabourdin N, Thomas M, Veyckemans F, Habre W; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Epidemiology and incidence of severe respiratory critical events in ear, nose and throat surgery in children in Europe: A prospective multicentre observational study. Eur J Anaesthesiol. 2019 Mar;36(3):185-193. doi: 10.1097/EJA.0000000000000951.
PMID: 30640246DERIVEDEngelhardt T, Virag K, Veyckemans F, Habre W; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Airway management in paediatric anaesthesia in Europe-insights from APRICOT (Anaesthesia Practice In Children Observational Trial): a prospective multicentre observational study in 261 hospitals in Europe. Br J Anaesth. 2018 Jul;121(1):66-75. doi: 10.1016/j.bja.2018.04.013. Epub 2018 May 18.
PMID: 29935596DERIVEDHabre W, Disma N, Virag K, Becke K, Hansen TG, Johr M, Leva B, Morton NS, Vermeulen PM, Zielinska M, Boda K, Veyckemans F; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017 May;5(5):412-425. doi: 10.1016/S2213-2600(17)30116-9. Epub 2017 Mar 28.
PMID: 28363725DERIVED
Study Officials
- STUDY CHAIR
Walid Habre, M.D.
University Hospital, Geneva
- STUDY DIRECTOR
Francis Veyckemans, M.D.
Cliniques Universitaires St Luc asbl Brussels
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2013
First Posted
June 17, 2013
Study Start
March 1, 2014
Primary Completion
January 1, 2015
Study Completion
April 1, 2015
Last Updated
October 14, 2015
Record last verified: 2015-10